Breakthrough, Therapy

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

07.08.2025 - 18:06:48 | prnewswire.co.uk

Simcere Pharmaceutical Group Limited China

View original content:https://www.prnewswire.co.uk/news-releases/breakthrough-therapy-designation-for-sanbexin-sublingual-tablets-granted-by-the-united-states-food-and-drug-administration-302248345.html

en | GB0006731235 | BREAKTHROUGH | boerse | 67952647 |